NCT04523168
Completed
N/A
A Phase II Study Testing the Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction
Amir Lerman1 site in 1 country30 target enrollmentJune 28, 2021
ConditionsCoronary Microvascular Dysfunction
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Coronary Microvascular Dysfunction
- Sponsor
- Amir Lerman
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Change in Coronary Flow Reserve (CFR)
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This study is being done to evaluate the role of a novel implantable device, called The Neovasc Reducer™ System, in improving microvascular function, symptoms and quality of life in symptomatic patients with coronary microvascular dysfunction.
Investigators
Amir Lerman
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Change in Coronary Flow Reserve (CFR)
Time Frame: Baseline, 120 days
Coronary flow reserve is calculated as the ratio of hyperemic or maximal flow down a coronary vessel to the resting coronary blood flow.
Secondary Outcomes
- Change in Canadian Cardiovascular Society (CCS) Angina Class(Baseline, 120 days)
- Seattle Angina Questionnaire (SAQ)(120 days)
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Clinical Assessment of New Speaking Valve With Heat and Moisture Exchanger (HME) for Tracheotomized PatientsTracheostomyNCT01976819Atos Medical AB16
Completed
N/A
Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence DeviceUrinary Bladder, OveractiveNCT04001426FemPulse Corporation2
Completed
N/A
The Clinical Efficacy of RENASYS TOUCH NPWT System in the Management of Acute, Sub-acute and Chronic WoundsWound and InjuriesSurgical Wound DehiscenceNCT02565043Smith & Nephew, Inc.80
Completed
N/A
Feasibility Study of an Innovative Medical Device for Sampling the Contents of the Small Intestine.Healthy VolunteersNCT05477069University Hospital, Grenoble16
Completed
N/A
An early clinical feasibility study of a new prosthesis: the NewBreez® Intralaryngeal device; a possible solution for severe aspiration in head and neck cancer patientsaspirationDysfunctional larynxswallowing impairment10027656NL-OMON42228Antoni van Leeuwenhoek Ziekenhuis5